- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06585475
Investigation of the Effectiveness of Structured Education According to Premenstrual Syndrome Symptom Map
September 3, 2024 updated by: Sakarya University
The Effectiveness of Structured Training According to the Premenstrual Syndrome Symptom Map
In this study, it was aimed to evaluate the effectiveness of the training structured according to the PMS symptom map.
This experimental (randomised-controlled) study was conducted with women of reproductive age with PMS.
Women who met the inclusion criteria and volunteered to participate in the study constituted the sample of the study.
As a result of block randomisation, 55 women were assigned to the intervention group and 55 women to the control group.
Pre-test data were collected from the women allocated to the intervention and control groups by means of data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, Premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale).
The intervention group received a 3-session structured training according to the PMS symptom map, while the control group did not receive any intervention.
Women in the intervention group completed the post-test data on the last day of the 2nd cycle after the training, while women in the control group completed the post-test data on the last day of the 2nd cycle after the pre-test.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sakarya, Turkey, 54050
- Sakarya University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Meeting ACOG's PMS diagnostic criteria Being over 18 years of age, Not using psychotherapeutic medications, Not having a mental illness, Not being pregnant, Agreeing to participate in the study
Exclusion Criteria:
Not having regular menstruation in the last 3 months, Using analgesics during menstruation while participating in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
The intervention group received a 3-session PMS symptom map-structured training by the responsible and first author (ADK).
Before the training, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale).
After the training, post-test data were collected on the last day of the 1nd cycle.
|
A symptom map consisting of evidence-based practices for coping with PMS symptoms was created.
An educational content based on this map was prepared and applied to women with PMS to evaluate whether it was effective compared to the control group.
|
|
No Intervention: Control group
No intervention was applied to the control group.
After the participants were divided into groups by randomization, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety rating scale, premenstrual syndrome rating scale and premenstrual syndrome specific life satisfaction scale).
After the pre-test, post-test data were collected on the last day of the cycle after 1 menstrual cycles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Premenstrual syndrome assessment scale
Time Frame: pre-intervention, 2 month after intervention
|
a scale used to measure the degree of premenstrual syndrome
|
pre-intervention, 2 month after intervention
|
|
premenstrual syndrome specific life satisfaction scale
Time Frame: pre-intervention, 2 month after intervention
|
Premenstrual syndrome specific life satisfaction scale evaluates life satisfaction of women with PMS
|
pre-intervention, 2 month after intervention
|
|
DAS depression stress anxiety assessment scale
Time Frame: pre-intervention, 2 month after intervention
|
DAS depression stress anxiety assessment scale, evaluates psychological symptoms
|
pre-intervention, 2 month after intervention
|
|
VAS pain score
Time Frame: pre-intervention, 2 month after intervention
|
1.421 / 5.000 VAS pain score measures pain score
|
pre-intervention, 2 month after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Actual)
June 10, 2024
Study Completion (Actual)
August 5, 2024
Study Registration Dates
First Submitted
September 3, 2024
First Submitted That Met QC Criteria
September 3, 2024
First Posted (Estimated)
September 5, 2024
Study Record Updates
Last Update Posted (Estimated)
September 5, 2024
Last Update Submitted That Met QC Criteria
September 3, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23.08.2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Education
-
Isfahan University of Medical SciencesNot yet recruitingEducation | Education, Medical | Education, Medical, Undergraduate
-
Isfahan University of Medical SciencesNot yet recruitingEducation | Education, Medical | Education, Medical, Undergraduate
-
University of KyreniaRecruiting
-
University of Modena and Reggio EmiliaCompletedNursing Education | Education, Competency-Based | Education, Nursing Students | Active Learning Methods and Life-skills Education | Evidence Based Practice | Evidence Based Programs in Schools | Education Advancement | Evidence Based Nursing | Nursing Education in Evidence-Based PracticeItaly
-
Sakarya UniversityRecruiting
-
Agri Ibrahim Cecen UniversityCompletedEducation | Gameifaction | Midwifery EducationTurkey (Türkiye)
-
Istanbul University - Cerrahpasa (IUC)Istinye UniversityActive, not recruitingEducation | Newborn; Vitality | Breastfeeding EducationTurkey
-
Ankara UniversityNot yet recruitingNursing Education | Education | Cultural Adaptation
-
Baskent UniversityCompletedNursing Education | Nursing Education ResearchTurkey (Türkiye)
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)RecruitingCancer Education | Spanish Language Cancer EducationUnited States, Puerto Rico
Clinical Trials on Structured training according to premenstrual syndrome symptom map
-
Hatice KarabulakAtaturk UniversityCompletedHave a Diagnosis of Coronary Artery DiseaseTurkey
-
Eskisehir Osmangazi UniversityCompletedEssential Hypertension | Cardiovascular Disease Risk | Motivational Interview | Healthy Lifestyle BehaviorTurkey